Marco Montillo
- Genetics top 0.1%
- Pathology and Forensic Medicine top 0.2%
- Immunology top 2%
- Hematology top 0.5%
- Oncology top 5%
- Co-authors
- Enrica MorraAlessandra TedeschiTadeusz RobakPeter HillmenThomas J. KippsRoberto CairoliUlrich JaegerAnnamaria Nosari
- Topics
- Chronic Lymphocytic Leukemia Research (126 papers)Lymphoma Diagnosis and Treatment (86 papers)Immunodeficiency and Autoimmune Disorders (50 papers)
- Journals
- New England Journal of MedicineJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- ItalyUnited StatesUnited Kingdom
In The Last Decade
Marco Montillo
151 papers receiving 4.6k citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Genetics 3.0k
- Pathology and Forensic Medicine 2.4k
- Immunology 1.3k
- Hematology 1.3k
- Oncology 797
Countries citing papers authored by Marco Montillo
This map shows the geographic impact of Marco Montillo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Montillo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Montillo more than expected).
Fields of papers citing papers by Marco Montillo
This network shows the impact of papers produced by Marco Montillo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Montillo. The network helps show where Marco Montillo may publish in the future.
Co-authorship network of co-authors of Marco Montillo
This figure shows the co-authorship network connecting the top 25 collaborators of Marco Montillo. A scholar is included among the top collaborators of Marco Montillo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Montillo. Marco Montillo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 8 | |
| 3 | 1 | |
| 4 | 2 | |
| 5 | 31 | |
| 6 | 33 | |
| 7 | 7 | |
| 8 | INTERIM RESULTS FROM A PHASE IIA STUDY OF THE ANTI-CXCL12 SPIEGELMER OLAPTESED PEGOL (NOX-A12) IN COMBINATION WITH BENDAMUSTINE/RITUXIMAB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA | 2 |
| 9 | 58 | |
| 10 | 10 | |
| 11 | 21 | |
| 12 | 6 | |
| 13 | Bendamustine versus chlorambucil in treatment- naive patients with chronic lymphocytic leukemia: Updated results of an international phase III study | 1 |
| 14 | 111 | |
| 15 | 17 | |
| 16 | 44 | |
| 17 | 39 | |
| 18 | 94 | |
| 19 | 67 | |
| 20 | 1 |
About Marco Montillo
Marco Montillo is a scholar working on Genetics, Pathology and Forensic Medicine and Hematology, having authored 156 papers that have together received 4.7k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (126 papers), Lymphoma Diagnosis and Treatment (86 papers) and Immunodeficiency and Autoimmune Disorders (50 papers). The work is most often cited by research in Genetics (3.0k citations), Pathology and Forensic Medicine (2.4k citations) and Hematology (1.3k citations). Marco Montillo has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Enrica Morra, Alessandra Tedeschi, Tadeusz Robak, Peter Hillmen, Thomas J. Kipps, Roberto Cairoli, Ulrich Jaeger, Annamaria Nosari, Javier Loscertales and Javier de la Serna. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.